MU eyes strong Q1 gains as AI-driven memory demand, better pricing and new chip ramps set the stage for a robust earnings ...
Zscaler (ZS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
The Tech sector has been driving aggregate earnings growth since 2023 Q3, and the trend is expected to continue in 2025 Q4 and beyond. For Q4, Tech sector earnings are expected to be up +13% from the ...
We recently published 10 Big Names Leaving Wall Street in the Dust; 4 at Fresh Highs. Amicus Therapeutics, Inc. (NASDAQ:FOLD) ...
Surprisingly, the Russell 2000 has a chance to be the second-best-performing index on the U.S. stock exchanges as we start to ...
HANOVER, Md. (AP) — HANOVER, Md. (AP) — Ciena Corp. (CIEN) on Thursday reported fiscal fourth-quarter profit of $19.5 million ...
Netskope expects full-year results to range from a loss of 53 cents per share to a loss of 51 cents per share, with revenue ranging from $701 million to $703 million.
Zacks Investment Research on MSNOpinion

3 gas distribution stocks to buy from a challenging industry

Natural gas distribution companies offer services to transport natural gas from the region of production to millions of ...
NEW YORK (AP) — NEW YORK (AP) — Mesabi Trust (MSB) on Friday reported net income of $2.8 million in its fiscal third quarter. The New York-based company said it had profit of 21 cents per share. The ...
Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.